Cutaneous sıde‐effects of the potential COVID‐19 drugs-Reference-Cited by-同舟云学术

Cutaneous sıde‐effects of the potential COVID‐19 drugs

Published:2020-05-22 Issue:4 Volume:33 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Türsen Ümit¹^ORCID,Türsen Belma²^ORCID,Lotti Torello³^ORCID

Affiliation:

1. Department of Dermatology School of Medicine, Mersin University Mersin Turkey

2. Department of Health Science Toros University Mersin Turkey

3. Department of Dermatology School of Medicine, Marconi University Rome Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13476

Reference49 articles.

1. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020

2. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019‐nCoV) infected pneumonia (standard version);Ying‐Hui J;Mil Med Res,2020

3. Clinical outcomes of hydroxichloroquine in hospitalized patients with COVID‐19: a quasi‐randomized comparative study;Joshua B;N Eng J med,2020

4. Increased cutaneous reactions to hydroxychloroquine (Plaquenil) possibly associated with formulation change: Comment on the letter by Alarcón

5. Cutaneous manifestations in COVID‐19: a first perspective

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The most common skin symptoms in young adults and adults related to SARS-CoV-2 virus infection;Archives of Dermatological Research;2024-05-31

2. Viral Infections;Rook's Textbook of Dermatology;2024-03-19

3. A Comprehensive Review on Potentially Therapeutic Agents against COVID-19 from Natural Sources;Current Traditional Medicine;2024-02

4. Network pharmacology combined with molecular docking simulations reveal the mechanism of action of Glycyrrhiza for treating pneumonia;Peptide Science;2024-01-17

5. Monkeypox 2022 vs. COVID-19: a Review on a National Health Emergency with Emphasis on Cutaneous Manifestations;Current Infectious Disease Reports;2023-09-18